The Psychedelic Podcast cover image

Graham Pechenik - The Psychedelic Patent Puzzle: Unraveling the Impact on Innovation vs. Access

The Psychedelic Podcast

00:00

The Importance of Patents in Innovation

Many people point out that the types of new drugs that come to market are often copycat drugs. They may have some very minimal variation that sort of passes the test for patentability so they can get longer patent life or new patent life on it, but it doesn't really provide any therapeutic advantage. Is S-Cettamine substantially different enough that it's worth the additional costs that it has over receiving Ketamine? Does it really provide an advantage? And if we look at all the activity going on now, and certainly there's a lot of companies who are bringing new drugs through approval or through preclinical trials. How are these, I guess, providing advantages over and above just the advantage

Play episode from 35:45
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app